Key Statisticslimited data
Market Cap$2.81M
P/E RatioN/A
Div. Yield—
EPS (TTM)—
52W High—
52W Low—
Sector—
Industry—
Employees—
Price Performance
1 Week+13.29%
3 Month-29.58%
1 Year-53.37%
About
XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease, hypertension, insulin resistance, and diabetic nephropathy. The company is headquartered in Vancouver, Canada.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze XRTX with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.
